2001
DOI: 10.3892/or.8.6.1269
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics and pharmacodynamics of serum platinum of gynecologic cancer patients treated with nedaplatin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…However, according to a study, in these patients, the serum level of nedaplatin remained high for a long duration, and side effects, including renal toxicity, should be considered. 21) The grade of nephrotoxicity related to nedaplatin and cisplatin was dose dependent, and was similar at the doses at which kidney accumulation was similar. A study has reported that cisplatin-related nephrotoxicity is dose-dependent 10,11) ; our results supported this finding.…”
Section: Discussionmentioning
confidence: 89%
“…However, according to a study, in these patients, the serum level of nedaplatin remained high for a long duration, and side effects, including renal toxicity, should be considered. 21) The grade of nephrotoxicity related to nedaplatin and cisplatin was dose dependent, and was similar at the doses at which kidney accumulation was similar. A study has reported that cisplatin-related nephrotoxicity is dose-dependent 10,11) ; our results supported this finding.…”
Section: Discussionmentioning
confidence: 89%